Lithium
If a doctor has prescribed lithium for you or someone close to you, you may
wish to know more about the medication Is it safe? Will it cause discomfort?
Most importantly, will it work? Chances are you've been told hat lithium may
prevent future bouts of your illness. You can benefit from this remarkable
effect only if you continue to take the drug exactly as the doctor
prescribes. You may have to take it for long periods of time, perhaps
indefinitely. That means lithium is as important to you as insulin is to a
diabetic or other kinds of daily medications are to people with high blood
pressure. Like a diabetic or hypertensive person, you may question whether
you need to continue taking the medication day after day, especially if you
feel well. But lithium can save your life as surely as those other drugs
save theirs. This pamphlet will help you learn more about lithium.
Lithium: Mineral and Drug
Pure lithium, like sodium, calcium, or potassium, is a naturally
occurring
mineral. Lithium is found abundantly in certain rocks and the sea and
in
minute amounts in plant and animal tissues. Lithium also shows up in
water,
notably in the springs and spas where in earlier times people "took the
waters," bathing in and drinking the lithium-rich water for its
soothing
effects. Whether lithium actually calmed 14th-century ladies and
gentlemen
has never been documented. What we do know is that, from time to time
since
antiquity, doctors have noticed that lithium can control over
excitement
in some of their patients. Today, lithium is administered to patients
as
a lithium salt, usually as lithium carbonate or lithium citrate, which
is taken by mouth in capsule, tablet, or syrup form. Pharmaceutical
companies
often assign a "trade name" to their products. Examples of trade names
for lithium are Cibalith, Eskalith, Lithane, and Lithobid. Some
companies
use only the chemical name, that is, lithium carbonate or lithium
citrate.
Modern physicians rely on these various forms of lithium to treat
serious
mental illness. Properly administered, it is one of the most powerful
medications
available for mood disorders.
What Are Mood Disorders?
Patients with mood disorders, also called affective disorders,
suffer
from depression. In contrast to "the blues" that we all go through, a
depressive
episode is a true illness, often referred to as clinical depression.
Some patients also experience episodes of mania-intense
excitement
and mental disorganization that usually require immediate
hospitalization.
Although mania is popularly thought of as a state of excess euphoria,
patients
report that a depressive mood is as frequent as euphoria during a manic
episode, and irritability is the most common symptom. According to the
National Institute of Mental Health (NIMH)-the Federal agency that
supports
research nationwide on the causes, treatment, and prevention of mental
illness-depression is one of the most common mental disorders. The
latest
NIMH surveys indicate that during the course of a year, 5 in every 100
Americans has an episode of clinical depression and another 1.2 percent
has an episode of
manic-depressive illness that might consist of
mania, depression, or the combination of both. Unlike the ups and downs
of everyday life, clinical depression envelops a person in a dark cloud
of gloom and lethargy. Often, no cause can be found for the extreme
sadness-no
death or financial setback or ruined romance. Although such losses can
trigger a depressive episode, the sadness and apathy of clinical
depression
are deeper and go on far longer than is usual when a person grieves a
loss.
Without treatment, depression can continue for years, but typically it
will last from 4 to 12 months. During a depressive episode, thinking
slows
down, concentration and memory are impaired, decisions are difficult to
make, eating and sleeping habits may become disrupted, and
anxiety-sometimes
in the form of panic attacks-can add to the individual's overall
misery.
People with depression usually feel that they have lost their value,
that
they are no good to anyone. When they also lose all hope of regaining
their
sense of self-worth, some may come to feel that suicide is the only
option
left to them. In fact, about one in five individuals with depression
will
attempt suicide. In some people, the "lows" of depression more or less
alternate with the "highs" of mania. In its early stages, mania may
feel
much like waking on a sunny day full of energy, good will, and high
spirits,
with a head full of ideas. These periods of hypomania that is,
something
less than full-blown mania pleasurable as they are, can quickly
progress
to true mania. By the time a person has reached that stage, thoughts
are
racing so fast that it is impossible to carry through any one idea.
Good
judgment vanishes. Manic individuals may spend the family into
bankruptcy,
engage m multiple sexual liaisons, pick fights with the boss, start
grandiose
projects that have no chance of success, grow angry too quickly, drink
far too much, and generally convey the impression that they are not
bound
by earthly limitations on time, the need for sleep, or consideration of
others. As this strange mix of symptoms implies, depression and mania
are
part of the same illness, bipolar disorder, which is also
called
manic-depressive
illness. The mix of depression and mania varies tremendously from
one
patient to the next, as does the timing of episodes and their duration.
Some people may experience both depression and mania at the same time;
these are the mixed states that doctors sometimes refer to.
Some
patients cycle rapidly from one state to the other, sometimes within
the
course of a day. Some people have episodes of clinical depression
alternating
with hypomania that never progresses to mania; this form is usually
called
bipolar-II
illness. Severe depression that occurs without mania is usually
referred
to as unipolar depression, clinical depression, major depression
or, sometimes, the classic term, melancholia. Left untreated,
manic-depressive
illness nearly always recurs. A first episode in the late teens or
early
twenties, the typical age of onset, tends to be followed by episodes
that
get closer and closer and then settle into a somewhat regular pattern
of
recurrences. Unipolar depression may also recur. In either case, these
illnesses rob the patient of years of life. Much of that suffering can
be avoided with lithium and other treatments. Mania and clinical
depressions,
especially the forms that tend to recur, clearly reelect some
malfunction
in the brain. Scientists have been able to use new brain imaging
technologies
to picture such differences. In addition, research on the biochemical
aspects
of these illnesses suggests that faulty regulation of neurotransmitter,
the chemical messengers that help nerve cells to communicate, is
involved
in depression and mania. Also important are various hormones,
especially
those that regulate the body's response to stress. Scientists have
learned
enough about these processes to realize that, so far, they know only
part
of the story. They have also developed a profound respect for the
complexity
of the human brain. One surprisingly complex aspect of the brain is its
capacity to change, to be influenced by the person's experience-losing
a parent at a critical age in childhood, for example, or feeling under
great pressure at home or work from time to time. Such experiences can
produce physical changes in the central nervous system and affect the
brain's
capacity to regulate mood. In some people, these adverse experiences
may
trigger the changes that end in clinical illness.
The Development of Lithium Treatment
John Cade, an Australian physician, introduced lithium into psychiatry
in 1949 when he reported that lithium carbonate was an effective
treatment
for manic excitement. Unfortunately, Dr. Cade's discovery coincided
with
reports of several deaths from the unrestricted use of lithium chloride
as a salt substitute for cardiac patients. Four patients died, and
several
developed toxic reactions. It was not known at that time that lithium
can
accumulate to dangerous levels in the body or that lithium has to be
used
with special caution in patients with cardiac disorders. As a result of
these experiences, lithium was virtually neglected in this country
until
the early 1960s. Research by European psychiatrists, especially Dr.
Mogens
Schou in Denmark, hastened acceptance of lithium in the United States.
Renewed interest in the compound led to numerous clinical trials,
including
pivotal studies conducted by NIMH. These studies showed how lithium
could
be used safely and effectively to treat psychiatric disorders. In
addition,
research-both in animals and humans-showed that lithium influences
several
functions in the body, including the distribution of sodium and
potassium,
which regulate impulses along the nerve cells. Lithium can affect the
activity
of neurotransmitter and biological systems because it alters the way in
which a variety of messages are transmitted after they reach their
target.
Although scientists have many promising leads, they have yet to explain
the biochemical actions of depression. In 1970, the U.S. Food and Drug
Administration (FDA) approved lithium as a treatment for mania. Four
years
later, the FDA also approved the use of lithium as a preventive, or
prophylactic,
treatment for manic-depressive illness.
Lithium's Uses
Psychiatrists use lithium in two ways: to treat episodes of mania and
depression
and to prevent their recurrence. Lithium can often subdue symptoms when
a patient is in the midst of a manic episode, and it may also
ameliorate
the symptoms of a depressive episode. The single most important use for
lithium, though, is in preventing new episodes of mania and depression.
Lithium is also being used experimentally to treat other
disorders.
Manic and Depressive Episodes
Lithium is highly effective in treating acute episodes of mania,
especially
when symptoms are mild. Patients going through severe manic episodes
need
to be calmed as quickly as possible, however, and lithium may take 1 to
3 weeks to achieve its full effect. Therefore, physicians most often
treat
very disturbed patients by first combining lithium with a different
type
of drug, a tranquilizer, such as haloperidol or chlorpromazine. When
lithium
has had a chance to act, the tranquilizer may be gradually withdrawn.
Lithium
can normalize the manic disorder without causing the drugged feeling
that
often occurs with tranquilizers. Also, tranquilizers may produce
troublesome
side effects that limit their usefulness as a long-term treatment.
Lithium
is also effective in treating depressive episodes in some patients with
manic-depressive illness. For these patients, some doctors prefer to
treat
mild to moderate depressive episodes with lithium alone because of the
possibility that conventional anti-depressant drugs such as imipramine
may trigger a hypomanic or manic attack. If the depression is severe,
treatment
is usually begun with a conventional antidepressant in combination with
lithium. That same combination is sometimes used in unipolar
depressions
that do not respond to anti- depressant medications alone.
Lithium's Role in Preventing Manic and Depressive Episodes
As noted, lithium's greatest value is in preventing or reducing the
occurrence
of future episodes of bipolar disorder. The effectiveness of this lithium
prophylaxis or lithium prophylactic treatment has been demonstrated
in more than two decades of careful research. In related research,
several
major studies indicate that lithium can decrease the frequency or
severity
of new depressive episodes in recurrent unipolar disorder. This
suggests
that lithium may also have prophylactic value in treating this mood
disorder.
Conventional antidepressants also have been shown to be effective
prophylactic
treatment for recurrent unipolar depression. In prophylactic treatment,
lithium is administered after a manic or depressive episode to prevent
or dampen future attacks. Some patients respond quickly and have no
further
episodes. Others respond more slowly and continue to have moderate mood
swings even months after therapy is started. These highs or lows
usually
become progressively less severe with continued lithium treatment;
often
they disappear. With other patients, lithium may not prevent all future
manic and depressive episodes, but may reduce or lessen their severity
so that the individual can continue to lead a productive life. There
are
patients who are not helped at all by lithium. About one in ten
patients
with bipolar disorder who takes lithium does not respond to the
medication,
but continues to have manic-depressive episodes at the same frequency
and
severity as before. Doctors cannot predict with certainty how lithium
will
work in any individual case. This can be determined only by actual use
of the medication. When deciding whether a patient should start lithium
prophylactic therapy, a psychiatrist or other physician considers the
likelihood
of a new episode in the near future; the impact that the episode might
have on the patient, family, and job; the patient's willingness to
commit
himself or herself to a long-term treatment program; and the presence
of
medical conditions that may rule out lithium treatment. Usually, a
doctor
prescribes lithium prophylactic therapy only after a patient has had
two
or three well-defined episodes requiring treatment. Patients who have
had
only a single attack, mild attacks, or a long interval between
episodes-for
example, over 5 years-usually do not receive prophylactic treatment
unless
the second episode would be life threatening or highly disruptive to
the
patient's career or family relations. Such rules, though, serve as only
broad guidelines. Patients must act as the doctor's partner in weighing
the circumstances and making the decision. Each patient should
understand
the reasons for lithium prophylaxis is as well as the benefits and
risks
and be an informed participant in the treatment program. When lithium
fails
or when a patient has another medical condition that precludes its use,
the doctor may consider an alternative prophylactic drug treatment.
First,
however, he or she will reevaluate why lithium failed: Was dosage
adequate?
Did the patient take the medication as prescribed? Does the patient
have
a problem with thyroid function? Many patients with mood disorders have
malfunctioning thyroid glands, a problem that can be successfully
treated
with a thyroid hormone or related preparations without withdrawing
lithium.
For manic-depressive patients, the anticonvulsant drugs carbamazepine
(trade
name Tegretol) and valproate (trade name Depakote) seem to be the best
alternatives to lithium. Sometimes the anticonvulsant drugs are given
alone,
sometimes in combination with lithium, to prevent or dampen future
episodes.
Patients with unipolar disorder who fail on lithium often are given an
antidepressant drug alone or in combination with lithium. A severe
episode
may be treated with electroconvulsive therapy. Information on
alternatives
to lithium treatment can be found in the literature listed at the end
of
the pamphlet.
Other Disorders
Lithium may also be useful for treating other mental illnesses.
Research
psychiatrists have evaluated lithium as a treatment for a variety of
psychiatric
disorders, including schizophrenia, schizoaffective disorder,
alcoholism,
premenstrual depression, and periodic aggressive and explosive
behavior.
Lithium appears to produce the best responses in patients who have mood
swings, a tendency to have intermittent bouts of illness, or a family
history
of mood disorder.
Lithium's Side Effects
Most patients do not experience serious side effects when they begin
lithium
therapy. Initially, the patient may have slight nausea, stomach cramps,
diarrhea, thirstiness, muscle weakness, and feelings of being somewhat
tired, dazed, or sleepy. A mild hand tremor may emerge as the dose is
increased.
These effects are normally minimal and usually subside after several
days
of treatment. But some of the initial side effects may carry over into
long-term therapy and others may emerge. Some patients continue to have
a slight hand tremor. Many drink more fluids than usual without always
being aware of it-and urinate more frequently, while still others may
gain
weight. Weight gain often can be controlled with proper diet. Crash
diets
should be avoided, however, since they may adversely affect lithium
levels.
Also, to avoid excessive weight gain, excessive amounts of drinks with
high sugar content should be avoided. In patients who have low amounts
of thyroid hormone, enlargement of the thyroid gland may develop, but
this
condition is generally not serious if monitored closely by a physician.
It can be successfully treated with supplementary thyroid medication
without
withdrawing lithium. Because of physiological changes in kidneys
observed
in some lithium-treated patients, any past or current kidney disorder
or
changes in frequency of urination should be reported to the physician.
Long-term lithium therapy can also worsen certain skin conditions,
especially
acne and psoriasis, and may produce edema, or swelling, which is due to
accumulation of water in tissues. Lithium must be taken with care, with
attention to taking the proper dose, having regular blood tests, and
reporting
changes in diet, exercise, and the occurrence of illness. Toxic levels
of lithium in the blood can cause vomiting, severe diarrhea, extreme
thirst,
weight loss, muscle twitching, abnormal muscle movement, slurred
speech,
blurred vision, dizziness, confusion, stupor, or pulse irregularities.
Sudden physical or mental changes should be reported to the doctor
immediately.
These problems can almost always be avoided when the doctor's
instructions
are followed carefully.
Periodic Blood Tests
The amount of lithium needed to treat or prevent manic and depressive
symptoms
effectively differs greatly from one patient to another. The doctor
determines
how much lithium a patient needs by taking a sample of blood from time
to time. The blood is analyzed to determine how much lithium is
present.
Testing for the lithium blood level is a vital part of treatment with
lithium.
It aids the doctor in selecting and maintaining the most effective
dose.
Just as important, lithium blood levels assure the doctor that a
patient
is not taking a toxic dose-that is, a poisonous dose. Lithium is an
unusual
drug because the amount needed to be effective is only slightly less
than
the amount that is toxic. For that reason, patients must be very
careful
not to take more lithium than prescribed. Lithium levels in the blood
can
change even when the patient takes the same dose every day: The
concentration
of lithium can increase when a person becomes ill with another medical
condition, especially influenza or other illnesses that result in fever
or changes in diet and loss of body fluids. Surgery, strenuous
exercise,
and crash diets are other circumstances that can lead to dangerously
increased
lithium levels in the blood. The doctor should be informed of illness
or
changes in eating habits, and a regular blood testing schedule should
be
set up and followed rigorously. If a patient stops taking lithium for
only
one day, the blood level of the drug falls to half that needed for
effective
therapy. A forgotten dose should not, however, be taken with the
regular
dose the next day, because it could raise the lithium level too much.
Furthermore,
the lower lithium level that results from missing one dose is unlikely
to jeopardize therapeutic response. Because the blood level of lithium
rises rapidly for a few hours after swallowing a lithium pill and then
slowly levels off, having a blood test right after taking the drug can
mislead the doctor into thinking that the dose is too high. To gauge
the
average blood level accurately, it is important to have blood drawn
about
12 hours after the last dose of lithium. Otherwise, the results will be
misleading and possibly dangerous. Most patients take their nighttime
dose
of lithium and then come to the doctor's office the next morning to
have
a blood test before taking their first dose for the day. Some patients
are able to take their full daily dose at bedtime and don't have to
worry
about the morning dose when getting a blood level.
Precautions in Taking Lithium
Lithium is excreted from the body almost entirely by the kidneys. If,
for
some reason, the kidneys are unable to get rid of the proper amount of
lithium, the drug may accumulate to dangerous levels in the body. The
excretion
of Lithium in the kidneys is closely linked to that of sodium. The less
sodium, or salt, in the body, the less Lithium is excreted, and the
greater
chance of Lithium buildup to toxic levels. Diuretics cause the kidneys
to excrete sodium; as a result, Lithium levels rise. The reason that
many
illnesses can increase lithium levels is that increased sweating,
fever,
a low salt diet, vomiting, and diarrhea all result in less sodium
present
in the body, thus producing higher levels. Lithium should not be taken
by patients with severely impaired kidney function. Patients with heart
disease and others who have a significant change in sodium in their
diet
or periodic episodes of heavy sweating should be especially careful to
have their lithium blood levels monitored regularly. For women in the
fertile
age range, the possibility of harmful effects on the unborn child may
pose
problems for continued use of lithium. Children of mothers who received
lithium during the first 3 months of pregnancy have been reported in
some,
but not all, studies to have a slightly increased frequency of
malformations
of the heart and blood vessels. Even though this risk is low and
uncertain,
it is strongly recommended that women discontinue Lithium during the
first
3 months of pregnancy. The decision to stop the medication, however,
must
be weighed against the possible consequences of an untreated manic or
depressive
attack, which may result in injury, physiological stress, dehydration
and
malnutrition, sleep deprivation, or possibly even suicide. Because of
the
risk of postpartum depression or mania, lithium is sometimes restarted
during the final weeks before birth is expected. Women should not
breast
feed when they are taking lithium, except in rare circumstances when
the
potential benefits to the mother outweigh possible hazards to the
child.
Taking Lithium: How Long?
When fully effective, Lithium can control manic-depressive illness for
the rest of a person's life. But it is not a cure. Like
antihypertensive
medications for controlling high blood pressure, lithium should not be
discontinued without consulting the physician. Unfortunately, some
patients
stop taking their lithium when they find that it diminishes the
wonderful
sense of well-being they felt when hypomanic; most resume taking their
medication when disabling manic episodes return. Other patients
discontinue
Lithium because they feel they no longer need it. Such reasoning is
perfectly
understandable. When a person remains well week after week, there is a
tendency to forget to take lithium or to deliberately stop taking the
medication,
believing that the illness has been cured. Lithium's effects, however,
last only when patients regularly take the medication. If patients stop
taking Lithium-no matter if they've been taking it for 5 weeks or 5
years-the
hances of having another manic or depressive attack increase. In fact,
patients who stop taking the medication are just as likely as patients
who have never been treated to fall back into a manic or depressive
episode.
This does not mean, though, that all patients must take lithium for a
lifetime.
After a long period of treatment without a recurrence of mania or
depression,
the doctor and patient may consider withdrawal of medication under dose
supervision. That decision will depend upon several factors, including
the impact that a subsequent episode may have on the patient's marriage
or other significant relationships, career, and general functioning;
the
likelihood that an emerging recurrence will be detected early enough to
prevent a full-blown attack; and the patient's tolerance of
lithium.
A Checklist for Patients Taking Lithium
1. Take the medication on a regular
basis
as a prescribed by the doctor. Ask the doctor for instructions on what
to do if one or more doses are missed. Unless the doctor advises
otherwise,
do not catch up on the missed dose by doubling the next dose. This may
produce a dangerously high blood level of lithium.
2. Obtain regular blood tests for lithium
levels.
3. Have the doctor take blood tests for
lithium levels 12 hours after the last dose. Inform the doctor if it
has
been less than 11 hours or more than 13 hours since the last dose.
4. Inform the doctor if other medications
are being taken, since they can change lithium levels.
5. Notify the doctor whenever there is
a significant change in weight or diet. It is especially important to
tell
the doctor if you plan to begin a rapid weight-loss diet, since lithium
levels in the body may be drastically affected.
6. Advise the doctor about any changes
in frequency of urination, loss of fluids through diarrhea, vomiting,
excessive
sweating, or physical illness, particularly if there is a fever,
because
adjustment of dosage or further testing may be required.
7. If planning to become pregnant, advise
the doctor
8. If another doctor is being seen or an
operation is planned, be sure to inform that doctor that you are taking
lithium.
9. because it may take time for mood
swings
to be completely controlled by lithium, try not to get discouraged.
Continue
taking the medicine as prescribed until advised otherwise by the
doctor.
However, be sure to notify the doctor of the recurrences in mania or
depression
because it may be necessary to increase the dose or receive additional
medication for a time. Psychotherapy can help you recognize manic or
depressive
episodes early in their course, as well as help you to express and
understand
your feelings about having manic-depressive illness.
10. Ask the doctor any questions about
the treatment program or any procedures that you do not understand. A
well-informed
patient and family are important factors contributing to successful
treatment
outcome. Also. if your psycho-therapist is someone other than the
doctors
prescribing the medication, it is important for the two professional to
exchange information about your progress and problems as needed.
Information Resources
Suggested Reading
• Bohn, J., and Jefferson, J. Lithium and Manic Depression A Guide.
Rev.
ed. Madison, WI: Lithium Information Center, University of Wisconsin,
1990.
• Fieve, R. Moodswing: The Third Revolution in Psychiatry. Rev. ed.
New York: William Morrow and Company, 1989.
• Gold, M. The Good News About Depression. New York: Villard Books,
1987.
• Goodwin, F.K., and Jamison, K.R. Manic-Depressive illness. New York
and Oxford: Oxford University Press, 1990.
• Jefferson, J., and Greist, J. Valproate and Manic Depression: A
Guide.
Madison, WI: Lithium Information Center, University of Wisconsin, 1991.
• Jefferson, J.; Greist, J.; Ackerman, D.; and Carroll, J. Lithium
Encyclopedia for Clinical Practice. Rev. ed. Washington, DC: American
Psychiatric
Press, Inc., 1987.
• Johnson, F.N., ed. handbook of Lithium Therapy. Lancaster, England:
MTP Press Ltd., and Baltimore, MD: University Park Press, 1980.
• Johnson, F.N. Depression and Mania: Modern Lithium Therapy. Oxford:
IRL Press, 1987.
• Medenwald, J.; Greist, J.; and Jefferson, J. Carbamazepine and Manic
Depression: A Guide. Rev. ed. Madison, WI: Lithium Information Center,
University of Wisconsin, 1990.
• Post, R., and Uhde, T. Refractory manias and alternatives to lithium
treatment. In: Georgotis, A., and Cancro, R., eds. Depression and
Mania.
New York: Elsevier, 1988.
• Prien, R.F., and Potter, W.Z. National Institute of Mental Health
workshop report on treatment of bipolar disorder. psychopharmacology
Bulletin
26(4):409-427, 1990.
• Schou, M. Lithium treatment of manic-depressive illness: Past,
present,
and perspectives. Journal of the American Medical Association 259:1834
1836, 1988.
• Schou, M. Lithium Treatment of Manic-depressive illness: A Practical
Guide. Rev. ed. New York and Basel: Karger, 1989.
For More Information on Mood Disorders and Lithium
Dean Foundation
8000 Excelsior Drive,
Suite 203
Madison, WI 53717-1914
(608) 836-8070
-------------------------- All material in this pamphlet is free
of copyright restrictions and may be copied, reproduced, or duplicated
without permission from the Institute; citation of the source is
appreciated.
This booklet was written by Robert F. Prien, Ph.D., and William Z.
Potter,
M.D., Ph.D., psychopharmacology and manic-depressive illness experts,
National
Institute of Mental Health. Editors were Bette Runck and Lynn J. Cave,
NIMH.
Back